Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcq

Showing results (221-230 of 267) with videos related to

Pageof 27
Sort By:
Cancers|December 11, 2022
Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial GroupGautier Marcq, Luca Afferi, Yann Neuzillet, et al.
Scientific Reports|October 26, 2017
Cytoplasmic cyclin D1 controls the migration and invasiveness of mantle lymphoma cellsSimon Body, Anna Esteve-Arenys, Hadjer Miloudi, et al.
The Journal of Urology|July 25, 2024
The Impact of Histologic Subtypes on Clinical Outcomes After Radiation-Based Therapy for Muscle-Invasive Bladder CancerDaniel Halstuch, Ronald Kool, Gautier Marcq, et al.
Urologic Oncology|March 24, 2026
Endoscopic kidney-sparing surgery outcomes of high-grade upper tract urothelial cancerFrancesco Di Bello, Benjamin Pradere, Ekaterina Laukhtina, et al.
European Urology Oncology|January 25, 2026
Risk of Recurrence and Progression After Endoscopic Kidney-sparing Surgery for Upper Tract Urothelial CarcinomaAndrea Gallioli, Francesco Di Bello, Fabio Zattoni, et al.
Future Oncology (London, England)|April 27, 2026
Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancerLudovica Cella, Alessio Finocchiaro, Aleksander Ślusarczyk, et al.
JMIR Research Protocols|June 15, 2023
Audit, Feedback, and Education to Improve Quality and Outcomes in Transurethral Resection and Single-Instillation Intravesical Chemotherapy for Nonmuscle Invasive Bladder Cancer Treatment: Protocol for a Multicenter International Observational Study With an Embedded Cluster Randomized TrialKevin Gallagher, Nikita Bhatt, Keiran Clement, et al.
European Urology Open Science|May 6, 2026
The Impact of II-look Ureteroscopy on Survival in Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study of EAU-YAU Urothelial Working GroupAndrea Gallioli, Francesco Di Bello, Ekaterina Laukhtina, et al.
Haematologica|February 22, 2020
Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective studyVincent Camus, Mathieu Viennot, Justine Lequesne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2022
Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with CancerYana Debie, Jonas R M Van Audenaerde, Timon Vandamme, et al.
Pageof 27

Showing results (221-230 of 267) with videos related to

Sort By:
Pageof 27
Cancers|December 11, 2022
Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial GroupGautier Marcq, Luca Afferi, Yann Neuzillet, et al.
Scientific Reports|October 26, 2017
Cytoplasmic cyclin D1 controls the migration and invasiveness of mantle lymphoma cellsSimon Body, Anna Esteve-Arenys, Hadjer Miloudi, et al.
The Journal of Urology|July 25, 2024
The Impact of Histologic Subtypes on Clinical Outcomes After Radiation-Based Therapy for Muscle-Invasive Bladder CancerDaniel Halstuch, Ronald Kool, Gautier Marcq, et al.
Urologic Oncology|March 24, 2026
Endoscopic kidney-sparing surgery outcomes of high-grade upper tract urothelial cancerFrancesco Di Bello, Benjamin Pradere, Ekaterina Laukhtina, et al.
European Urology Oncology|January 25, 2026
Risk of Recurrence and Progression After Endoscopic Kidney-sparing Surgery for Upper Tract Urothelial CarcinomaAndrea Gallioli, Francesco Di Bello, Fabio Zattoni, et al.
Future Oncology (London, England)|April 27, 2026
Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancerLudovica Cella, Alessio Finocchiaro, Aleksander Ślusarczyk, et al.
JMIR Research Protocols|June 15, 2023
Audit, Feedback, and Education to Improve Quality and Outcomes in Transurethral Resection and Single-Instillation Intravesical Chemotherapy for Nonmuscle Invasive Bladder Cancer Treatment: Protocol for a Multicenter International Observational Study With an Embedded Cluster Randomized TrialKevin Gallagher, Nikita Bhatt, Keiran Clement, et al.
European Urology Open Science|May 6, 2026
The Impact of II-look Ureteroscopy on Survival in Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study of EAU-YAU Urothelial Working GroupAndrea Gallioli, Francesco Di Bello, Ekaterina Laukhtina, et al.
Haematologica|February 22, 2020
Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective studyVincent Camus, Mathieu Viennot, Justine Lequesne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2022
Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with CancerYana Debie, Jonas R M Van Audenaerde, Timon Vandamme, et al.
Pageof 27